Longitudinal studies also demonstrated that plasma NfL is effective in assessing disease progression and predicting neurodegeneration in older adults with Alzheimer's disease [97, 101]. The gene discussed is NEFL; the disease is early-onset autosomal dominant Alzheimer disease.